Crossmark

Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

Crossref DOI link: https://doi.org/10.1186/s12885-018-4498-z

Published Online: 2018-05-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Jung-Yun

Kim, Sunghoon

Kim, Young Tae

Lim, Myong Cheol

Lee, Boram

Jung, Kyu-Won

Kim, Jae Weon

Park, Sang-Yoon

Won, Young-Joo
Funding

Funding for this research was provided by:

National Cancer Center (NCC-1610200)

Yonsei University College of Medicine (2017-32-0033)
License Information

Text and Data Mining valid from 2018-05-29
More Information

Article History

Received: 27 September 2017

Accepted: 9 May 2018

First Online: 29 May 2018

Ethics approval and consent to participate

: Ethical approval for the research protocol was provided by the institutional review board of the National Cancer Center (NCC2017–0168) which waived the requirement for informed consent. The authorization for data processing was obtained from the National ‘Cancer Control Act’.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.